Studies indicate that GLP-1 therapies can reduce inflammation, protect against neurodegeneration, regulate hormone production and even modulate the brains reward system 6,7
More recently, GLP-1 RA drugs have been approved for weight loss, cardiovascular disease, and chronic kidney disease
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial
This was due to the fact that they ushered in a new era in obesity, helping to reshape attitudes to the condition and how it is treated
This means weeks of rebuilding to your therapeutic dose, during which your results suffer and you relive the initial side effects all over again
By addressing multiple risk factors, GLP-1 contributes to holistic wellness improvements beyond merely controlling diabetes